Inovalon To Acquire Intelligent Medication Management Company DrFirst

Combination will connect workflows across the medication journey, enabling faster access to therapy and improved patient outcomes

BOWIE, Md. and Arlington, Va. – November 11, 2026 – Inovalon, a leading provider of solutions empowering data-driven healthcare, and DrFirst, a leader in prescription and clinical workflow technology, today announced they have signed a definitive agreement for Inovalon to acquire DrFirst.

This combination will extend product reach into clinical workflows, add real-time prescription drug and prior authorization capabilities, and expand the breadth of customers each company can serve. The combination will put richer information and intelligent decision support directly into the workflows where healthcare decisions are being made, and will bring patients additional resources to improve medication access and adherence.

Greater connectivity across providers, payers, pharmacies and life sciences organizations will benefit the customers of both companies, help reduce some of the friction in healthcare delivery and improve health outcomes. Together, Inovalon and DrFirst will serve over 2,000 hospitals and 240,000 prescribing providers writing 241 million+ prescriptions a year across 270+ EHR integrations.

This acquisition is the next significant step in Inovalon’s growth, having invested steadily in technology and data capabilities that support the healthcare ecosystem. The addition of DrFirst will build on that strategy through sophisticated prescribing, prior authorization, benefit determination and patient communications offerings. Customers will gain increased access to provider, pharmacy and patient engagement services that support industry-leading pull-through of medication therapies.

“DrFirst brings customer-focused solutions that help doctors and other providers improve medication access and adherence for their patients. As we continue to invest in innovation, DrFirst’s clinical-grade AI will further extend our reach to the point of care, helping inform the clinical decisions that shape each patient’s treatment. Together, we will have the opportunity to make a meaningful difference in outcomes across healthcare," said Adam Kansler, CEO of Inovalon. “Founded over 25 years ago by technology visionary James F. Chen, DrFirst has repeatedly demonstrated its commitment to improving healthcare and outcomes for patients. We have deep respect for what the DrFirst team has built, and we intend to invest in the business, keep customers at the center of all we do, and create new opportunities for our teams as both companies enter their next phase of growth.”

“Joining Inovalon is a natural next step for DrFirst. For over 25 years, we've worked inside clinical workflows to simplify medication management for providers and patients. Inovalon's complementary workflows, data and analytics let us drive closer coordination with everyone involved in a prescription. That gives patients the best opportunity to get the medications they need faster and stay on the therapies that keep them healthy,” said Laizer Kornwasser, CEO of DrFirst.

Citigroup Global Markets Inc. is serving as exclusive financial advisor to DrFirst, and Skadden, Arps, Slate, Meagher & Flom LLP is serving as its legal advisor.  Goldman Sachs & Co. LLC is serving as financial advisor to Nordic Capital, Inovalon’s lead investor, and Inovalon. Kirkland & Ellis LLP is serving as legal advisor to Inovalon and Nordic Capital, and McDermott Will & Schulte is serving as Inovalon’s regulatory, privacy, and healthcare legal advisor.

The transaction is subject to required regulatory approvals and other customary closing conditions. For more information, please visit www.inovalon.com. 

About Inovalon

Inovalon is a leading provider of data and solutions empowering data-driven healthcare. We bring together national-scale connectivity, real-time primary source data access, and advanced analytics into a sophisticated platform empowering improved outcomes and economics across the healthcare ecosystem. The company’s analytics and capabilities are used by over 50,000 active, licensed customers, and are informed by the primary source data of more than 99 billion medical, pharmacy, and lab events across 1.1 million clinicians, 736,000 clinical settings, and 461 million unique lives. For more information, visit www.inovalon.com.

About DrFirst

For 25 years, healthcare IT pioneer DrFirst has empowered providers and patients to achieve better health through intelligent medication management. The company has won more than 25 awards for excellence and innovation, including TIME's list of the World's Top HealthTech Companies of 2026 and 2025, recognizing the company's medication management solutions and integrated workflows that make every step of the patient journey easier, from first prescription to ongoing adherence. DrFirst solutions help over 100 million patients a year and are used by more than 670,000 providers, 71,000 pharmacies, 270 EHRs, and over 2,000 hospitals in the U.S. To learn more, visit DrFirst.com.

Contact:

Whitney Swistock
Sr. Director, Corporate Communications, Inovalon
Whitney.Swistock@Inovalon.com

Ellen Wilcox, Media Relations, DrFirst
ewilcox@drfirst.com